Organic products expo to relocate from Baltimore to Boston to accommodate growth
BOULDER, Colo. New Hope Natural Media, a division of Penton Media, announced today that the company’s Natural Products Expo East/Organic Products Expo-BioFach America trade show will relocate from Baltimore to Boston in 2008.
Next year’s Natural Products Expo East will be held Oct. 15 to 18 at the Boston Convention and Exhibition Center to accommodate exhibitor and attendee growth, reflecting increased interest in the natural, organic and healthy products markets.
“As Natural Products Expo East expands to represent broader consumer markets and new channels of distribution in the healthy products industry, we needed a larger space to serve our customers,” stated Alan Peterson, senior vice president of the Trade Show Group for New Hope Natural Media. “The move to Boston is a positive step that signals increased success for the event.”
The Boston location will provide increased proximity to the retail buying audience of the Northeast, as well as the ability to provide lodging for more retailers closer to the convention center. The new location will feature a contiguous show floor for exhibitors and attendees.
Relora survey finds 91 percent positive response
SALINAS, Calif. Next Pharmaceuticals on Tuesday released the results of an open label study on Relora. The study was conducted at The LaValle Metabolic Institute in Cincinnati, Ohio among 1,291 participants who suffered from stress, sleeplessness and/or stress-related eating.
According to the survey, 91 percent of the subjects reported Relora helped them relax, 90 percent reported Relora helped them have a restful sleep and 86 percent reported Relora helped prevent stress-related eating.
“This study demonstrates that Relora can be a successful adjunct for individuals who experience stress and anxiety, or who turn to food when dealing with tension,” stated Charles Kosmont, chief executive officer of Next Pharmaceuticals. “There are many methods to managing stress, and Dr. LaValle’s clinical study supports the fact that Relora is a natural, safe and effective approach with no toxic side effects.”
Relora consists of a patented blend of Magnolia bark extract and a proprietary blend of Phellodendron bark extract developed by Next Pharmaceuticals for the dietary supplement and functional food and beverage industries. Dr. James LaValle, author of Cracking the Metabolic Code, was the principal investigator of the study.
The subjects rated the efficacy of Relora on a 5-point scale. The product was considered effective for stress, restful sleep and stress-related eating if the subject rated the product 3 or higher. This study was developed as an open label, single center, clinical trial involving a minimum of 500 subjects with mild to moderate stress. Dr. LaValle enrolled both male and female subjects in the study as appropriate from patients at his clinic.
Matrixx announces plans to enter antacid market with Xcid
NEW YORK Matrixx revealed plans to enter the antacid market with a product called Xcid early in 2009 Wednesday, during the Roth Conference Presentation held here. According to the company, the acid neutralizing category is currently measured at around $500 million.
Xcid, featuring “from the makers of Zicam” on the packaging, will contain maximum strength quantities of calcium carbonate and magnesium hydroxide in a liquid format and will be launched with three flavors. Liquid antacids are considered highly efficacious among consumers, Carl Johnson, Matrixx president and chief executive officer, said, but there aren’t many good-flavored products currently on the market.
Matrixx will also be entering the oral care market in 2009, and will potentially target the analgesic sector for future product development.